CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 8 No. 6
 

Treatment of Actinic Keratoses Is More Than Cosmetic Issue

June 1, 1999

NEW YORK—Actinic keratoses should be treated or removed, according to the consensus of the American Academy of Dermatology, American Cancer Society, and Skin Cancer Foundation. “It is not merely a cosmetic issue,” said Jeffrey Callen, MD, chief of the Division of Dermatology, University of Louisville. Because of their potential to develop into skin cancer, these lesions should be regarded as a serious health problem, he said at a media briefing sponsored by the Academy as part of its Melanoma/Skin Cancer Detection and Prevention Month.

Dr. Callen said that p53 gene mutations present in actinic keratoses are similar to those found in squamous cell carcinoma. “Forty percent of squamous cell carcinomas begin as actinic keratoses, but most people do not seek treatment for these skin lesions,” he said.

He said that physicians need to raise awareness of the connection between actinic keratoses and squamous cell carcinoma and to treat the sun-induced scaly patches early.

“Although it is possible to diagnose an actinic keratosis on the basis of clinical appearance, it can be difficult to distinguish an actinic keratosis from a squamous cell carcinoma without a biopsy. Since some actinic keratoses will progress to squamous cell carcinoma, patients should see a dermatologist when they or their primary caregivers are in doubt,” Dr. Callen said.

Those at greatest risk for progression are the elderly and those with compromised immune systems, including people with HIV disease, organ transplant patients, and others on immunosuppressive therapies. As individuals in these risk groups live longer, their impaired immune surveillance may not handle actinic keratoses as effectively as those in whom the immune system is intact. Actinic keratoses may also be a marker for other cancers, Dr. Callen pointed out.

There is a wide selection of treatments available for actinic keratoses, ranging from destruction with liquid nitrogen and chemical or cryogenic peels; chemotherapy with such agents as fluorouracil(Drug information on fluorouracil), tretinoin(Drug information on tretinoin), interferon, and calcitriol(Drug information on calcitriol); and removal through curettage (with or without electrosurgery), dermabrasion, and lasers. A new treatment pending FDA approval involves photodynamic therapy.

Dr. Callen declined to recommend a particular therapy, stating that physician and patient must decide which is the most appropriate treatment for a given lesion. Location, number, and patient lifestyle are among factors to be considered.

Actinic keratoses are typically found on sun-exposed areas in older people, the result of cumulative sun exposure over many years. Sun avoidance and protection with sunscreens and protective clothing may prevent new lesions and delay progression to invasive disease, since UV radiation has been shown to impair immune surveillance, Dr. Callen said.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy